Senior Director, Global Medical Director, Neuro-Oncology - #2185780

If you are a current Jazz employee please apply via the Internal Career site.

Jazz Pharmaceuticals is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.

The Senior Director, Global Medical Director, Neuro-Oncology will be the Medical Affairs lead for the Neuro-Oncology disease area, including in line and early assets. This role is a key member of Global Commercialization Organization Medical Affairs (GCOMA) Oncology and reports to the VP, Global Medical Franchise Lead, Oncology, Medical Affairs.

This is a new, hybrid role with dual responsibility for US and Global strategy and execution. This role will lead the US Neuro-Oncology Medical Affairs team, partnering closely with global development, EU/International and US cross-functional partners to create and deliver on medical affairs strategy and input operating with the US as the principal region approach. This is a strategic role with both people management and execution responsibilities and is accountable for ensuring the needs and priorities of the regions are represented and addressed through engagement with key partners across Jazz. The Senior Director, Global Medical Director ensures a deep understanding of customer, patient, and healthcare system needs are represented consistently across cross-functional discussions and decision-making forums.

This role will provide strategic leadership and contributions directly or through team members in support of the clinical development team to determine and align on future treatment landscape scenarios for assets in early development through commercialization for all Neuro-Oncology assets. The Senior Medical Director will inform and influence clinical development strategy, evidence plans and the target product profile for such products, with a bias toward the United States therapeutic landscape as the driver of strategic planning.

The role serves as a critical interface between Medical Affairs and global R&D, Early/Clinical Development, Global Product Development and Commercialization functions, to ensure regional insights and priorities are understood, communicated, and appropriately considered within the Global Product Team (GPT), Commercial Development Team (CDT), Medical Functional Matrix Team (FMT), and governance forums including the Portfolio Governance Committee (PGC) and Development Project Review Committee (DPRC). This role leads the US medical affairs team with responsibility to deliver strategy and execution in support of the US indications in Neuro-Oncology in alignment with Neuro-Oncology commercial leadership and partners in the US market.

Essential Functions/Responsibilities:

• Lead the global and US Medical Affairs Neuro-Oncology team to deliver all aspects of medical affairs strategy in support of pipeline and marketed products
• Lead the global medical Neuro-Oncology FMT
• Provide strategic and executional leadership and guidance to team members to deliver US medical plan in support of all indications and launch planning
• Lead and develop team members in high performing team culture
• Lead the development, maintenance, and execution of the Integrated Evidence Generation Plan Neuro-Oncology including investigator-sponsored studies, real-world evidence initiatives, health outcomes research, and Phase IV interventional studies, where appropriate
• Responsible for the development of the scientific narrative for Neuro-Oncology indications by identifying and advancing key analytic needs and informing the interpretation of pivotal trial data
• Represent and advocate for medical perspectives within global cross-functional teams and governance forums, including GPT, CDT, PGC, and DPRC
• Contribute Medical Affairs expertise to inform early development activities for early pipeline assets, including Target Product Profile (TPP) development, clinical trial design and lifecycle planning based on regional insights and aligned future therapeutic landscape scenarios
• Ensure regional needs and insights are appropriately considered in early/clinical development discussions, evidence-generation activities, and lifecycle planning
• Ensures awareness and Medical Affairs functional alignment on early/clinical development programs
• Maintain and apply a deep understanding of the competitive landscape to inform evidence generation strategy and internal development decisions
• Partner effectively across Medical Affairs, Clinical Development, Regulatory Affairs, Market Access, HEOR, RWE, Commercial, and other cross-functional teams to support evidence generation and scientific exchange
• Lead development and execution of publication strategy and publication plans in alignment with regional evidence needs and scientific priorities
• Support scientific communications, congress planning, advisory boards, and external engagement activities as required

Required Knowledge, Skills, and Abilities